1. Home
  2. MDCX vs CLPS Comparison

MDCX vs CLPS Comparison

Compare MDCX & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • CLPS
  • Stock Information
  • Founded
  • MDCX 2008
  • CLPS 2005
  • Country
  • MDCX Canada
  • CLPS Hong Kong
  • Employees
  • MDCX N/A
  • CLPS N/A
  • Industry
  • MDCX
  • CLPS Computer Software: Prepackaged Software
  • Sector
  • MDCX
  • CLPS Technology
  • Exchange
  • MDCX Nasdaq
  • CLPS Nasdaq
  • Market Cap
  • MDCX 33.8M
  • CLPS 33.9M
  • IPO Year
  • MDCX N/A
  • CLPS 2018
  • Fundamental
  • Price
  • MDCX $3.16
  • CLPS $1.19
  • Analyst Decision
  • MDCX Strong Buy
  • CLPS
  • Analyst Count
  • MDCX 1
  • CLPS 0
  • Target Price
  • MDCX $10.00
  • CLPS N/A
  • AVG Volume (30 Days)
  • MDCX 106.5K
  • CLPS 19.9K
  • Earning Date
  • MDCX 01-01-0001
  • CLPS 03-05-2025
  • Dividend Yield
  • MDCX N/A
  • CLPS 10.80%
  • EPS Growth
  • MDCX N/A
  • CLPS N/A
  • EPS
  • MDCX N/A
  • CLPS N/A
  • Revenue
  • MDCX N/A
  • CLPS $153,816,045.00
  • Revenue This Year
  • MDCX N/A
  • CLPS N/A
  • Revenue Next Year
  • MDCX N/A
  • CLPS N/A
  • P/E Ratio
  • MDCX N/A
  • CLPS N/A
  • Revenue Growth
  • MDCX N/A
  • CLPS 5.81
  • 52 Week Low
  • MDCX $1.80
  • CLPS $0.68
  • 52 Week High
  • MDCX $4.99
  • CLPS $1.70
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • CLPS 48.47
  • Support Level
  • MDCX N/A
  • CLPS $1.17
  • Resistance Level
  • MDCX N/A
  • CLPS $1.27
  • Average True Range (ATR)
  • MDCX 0.00
  • CLPS 0.07
  • MACD
  • MDCX 0.00
  • CLPS -0.00
  • Stochastic Oscillator
  • MDCX 0.00
  • CLPS 35.02

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

About CLPS CLPS Incorporation

CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.

Share on Social Networks: